Charles River Laboratories Announces Third-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Charles River Labs (CRL) PT Lowered to $464 at Jefferies
November 4, 2021 7:57 AM EDTJefferies analyst David Windley lowered the price target on Charles River Labs (NYSE: CRL) to $464.00 (from $480.00) while maintaining a Buy rating.
The analyst commented, "We are maintaining our Buy rating on 2 key factors: 1) we think demand is strong enough to support DD... More
Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance
November 3, 2021 7:09 AM EDTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.70, $0.12 better than the analyst estimate of $2.58. Revenue for the quarter came in at $895.9 million versus the consensus estimate of $908.19 million.
GUIDANCE:
Charles River Laboratories sees FY2021 EPS of $10.20-$10.30, versus the consensus of... More
